Copyright Reports & Markets. All rights reserved.

Global Coronary Artery Bypass Grafts (CABG) Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Coronary Artery Bypass Grafts (CABG) Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Coronary Artery Bypass Grafts (CABG) Market Size Growth Rate by Product
      • 1.4.2 Off-pump CABG
      • 1.4.3 On-pump CABG
      • 1.4.4 MI Direct CABG
    • 1.5 Market by End User
      • 1.5.1 Global Coronary Artery Bypass Grafts (CABG) Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Ambulatory Surgical Centers (ASCs)
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Coronary Artery Bypass Grafts (CABG) Market Size
      • 2.1.1 Global Coronary Artery Bypass Grafts (CABG) Revenue 2014-2025
      • 2.1.2 Global Coronary Artery Bypass Grafts (CABG) Sales 2014-2025
    • 2.2 Coronary Artery Bypass Grafts (CABG) Growth Rate by Regions
      • 2.2.1 Global Coronary Artery Bypass Grafts (CABG) Sales by Regions
      • 2.2.2 Global Coronary Artery Bypass Grafts (CABG) Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Coronary Artery Bypass Grafts (CABG) Sales by Manufacturers
      • 3.1.1 Coronary Artery Bypass Grafts (CABG) Sales by Manufacturers
      • 3.1.2 Coronary Artery Bypass Grafts (CABG) Sales Market Share by Manufacturers
      • 3.1.3 Global Coronary Artery Bypass Grafts (CABG) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Coronary Artery Bypass Grafts (CABG) Revenue by Manufacturers
      • 3.2.1 Coronary Artery Bypass Grafts (CABG) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Coronary Artery Bypass Grafts (CABG) Revenue Share by Manufacturers (2014-2019)
    • 3.3 Coronary Artery Bypass Grafts (CABG) Price by Manufacturers
    • 3.4 Coronary Artery Bypass Grafts (CABG) Manufacturing Base Distribution, Product Types
      • 3.4.1 Coronary Artery Bypass Grafts (CABG) Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Coronary Artery Bypass Grafts (CABG) Product Type
      • 3.4.3 Date of International Manufacturers Enter into Coronary Artery Bypass Grafts (CABG) Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Coronary Artery Bypass Grafts (CABG) Sales by Product
    • 4.2 Global Coronary Artery Bypass Grafts (CABG) Revenue by Product
    • 4.3 Coronary Artery Bypass Grafts (CABG) Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Coronary Artery Bypass Grafts (CABG) Breakdown Data by End User

    6 North America

    • 6.1 North America Coronary Artery Bypass Grafts (CABG) by Countries
      • 6.1.1 North America Coronary Artery Bypass Grafts (CABG) Sales by Countries
      • 6.1.2 North America Coronary Artery Bypass Grafts (CABG) Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Coronary Artery Bypass Grafts (CABG) by Product
    • 6.3 North America Coronary Artery Bypass Grafts (CABG) by End User

    7 Europe

    • 7.1 Europe Coronary Artery Bypass Grafts (CABG) by Countries
      • 7.1.1 Europe Coronary Artery Bypass Grafts (CABG) Sales by Countries
      • 7.1.2 Europe Coronary Artery Bypass Grafts (CABG) Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Coronary Artery Bypass Grafts (CABG) by Product
    • 7.3 Europe Coronary Artery Bypass Grafts (CABG) by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Coronary Artery Bypass Grafts (CABG) by Countries
      • 8.1.1 Asia Pacific Coronary Artery Bypass Grafts (CABG) Sales by Countries
      • 8.1.2 Asia Pacific Coronary Artery Bypass Grafts (CABG) Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Coronary Artery Bypass Grafts (CABG) by Product
    • 8.3 Asia Pacific Coronary Artery Bypass Grafts (CABG) by End User

    9 Central & South America

    • 9.1 Central & South America Coronary Artery Bypass Grafts (CABG) by Countries
      • 9.1.1 Central & South America Coronary Artery Bypass Grafts (CABG) Sales by Countries
      • 9.1.2 Central & South America Coronary Artery Bypass Grafts (CABG) Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Coronary Artery Bypass Grafts (CABG) by Product
    • 9.3 Central & South America Coronary Artery Bypass Grafts (CABG) by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Coronary Artery Bypass Grafts (CABG) by Countries
      • 10.1.1 Middle East and Africa Coronary Artery Bypass Grafts (CABG) Sales by Countries
      • 10.1.2 Middle East and Africa Coronary Artery Bypass Grafts (CABG) Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Coronary Artery Bypass Grafts (CABG) by Product
    • 10.3 Middle East and Africa Coronary Artery Bypass Grafts (CABG) by End User

    11 Company Profiles

    • 11.1 Medtronic
      • 11.1.1 Medtronic Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Medtronic Coronary Artery Bypass Grafts (CABG) Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Medtronic Coronary Artery Bypass Grafts (CABG) Products Offered
      • 11.1.5 Medtronic Recent Development
    • 11.2 Abbott
      • 11.2.1 Abbott Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Abbott Coronary Artery Bypass Grafts (CABG) Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Abbott Coronary Artery Bypass Grafts (CABG) Products Offered
      • 11.2.5 Abbott Recent Development
    • 11.3 MAQUET
      • 11.3.1 MAQUET Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 MAQUET Coronary Artery Bypass Grafts (CABG) Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 MAQUET Coronary Artery Bypass Grafts (CABG) Products Offered
      • 11.3.5 MAQUET Recent Development
    • 11.4 Terumo Medical
      • 11.4.1 Terumo Medical Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Terumo Medical Coronary Artery Bypass Grafts (CABG) Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Terumo Medical Coronary Artery Bypass Grafts (CABG) Products Offered
      • 11.4.5 Terumo Medical Recent Development
    • 11.5 Boston Scientific
      • 11.5.1 Boston Scientific Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Boston Scientific Coronary Artery Bypass Grafts (CABG) Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Boston Scientific Coronary Artery Bypass Grafts (CABG) Products Offered
      • 11.5.5 Boston Scientific Recent Development
    • 11.6 Edwards Lifesciences
      • 11.6.1 Edwards Lifesciences Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Products Offered
      • 11.6.5 Edwards Lifesciences Recent Development
    • 11.7 Ethicon (a subsidiary of Johnson & Johnson)
      • 11.7.1 Ethicon (a subsidiary of Johnson & Johnson) Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Ethicon (a subsidiary of Johnson & Johnson) Coronary Artery Bypass Grafts (CABG) Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Ethicon (a subsidiary of Johnson & Johnson) Coronary Artery Bypass Grafts (CABG) Products Offered
      • 11.7.5 Ethicon (a subsidiary of Johnson & Johnson) Recent Development
    • 11.8 Karl Storz
      • 11.8.1 Karl Storz Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Karl Storz Coronary Artery Bypass Grafts (CABG) Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Karl Storz Coronary Artery Bypass Grafts (CABG) Products Offered
      • 11.8.5 Karl Storz Recent Development
    • 11.9 Dextera Surgical
      • 11.9.1 Dextera Surgical Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Dextera Surgical Coronary Artery Bypass Grafts (CABG) Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Dextera Surgical Coronary Artery Bypass Grafts (CABG) Products Offered
      • 11.9.5 Dextera Surgical Recent Development
    • 11.10 HeartWare
      • 11.10.1 HeartWare Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 HeartWare Coronary Artery Bypass Grafts (CABG) Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 HeartWare Coronary Artery Bypass Grafts (CABG) Products Offered
      • 11.10.5 HeartWare Recent Development
    • 11.11 Neograft
    • 11.12 Novadaq Technologies Inc
    • 11.13 Teleflex
    • 11.14 Genesee BioMedical

    12 Future Forecast

    • 12.1 Coronary Artery Bypass Grafts (CABG) Market Forecast by Regions
      • 12.1.1 Global Coronary Artery Bypass Grafts (CABG) Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Coronary Artery Bypass Grafts (CABG) Revenue Forecast by Regions 2019-2025
    • 12.2 Coronary Artery Bypass Grafts (CABG) Market Forecast by Product
      • 12.2.1 Global Coronary Artery Bypass Grafts (CABG) Sales Forecast by Product 2019-2025
      • 12.2.2 Global Coronary Artery Bypass Grafts (CABG) Revenue Forecast by Product 2019-2025
    • 12.3 Coronary Artery Bypass Grafts (CABG) Market Forecast by End User
    • 12.4 North America Coronary Artery Bypass Grafts (CABG) Forecast
    • 12.5 Europe Coronary Artery Bypass Grafts (CABG) Forecast
    • 12.6 Asia Pacific Coronary Artery Bypass Grafts (CABG) Forecast
    • 12.7 Central & South America Coronary Artery Bypass Grafts (CABG) Forecast
    • 12.8 Middle East and Africa Coronary Artery Bypass Grafts (CABG) Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Coronary Artery Bypass Grafts (CABG) Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG, pronounced "cabbage") surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery. A normal coronary artery transports blood to and from the heart muscle itself, not through the main circulatory system.
      The availability of favorable reimbursement policies for medical devices as one of the primary growth drivers for the global coronary artery bypass graft (CABG) market.
      The coronary artery bypass graft (CABG) market is experiencing considerable growth in the Americas due to the increasing prevalence of diseases such as coronary artery disease (CAD), cardiovascular diseases (CVD), stroke, and peripheral artery disease (PAD).
      A large number of patients highly prefer hospitals over other healthcare centers because hospitals extensively perform complex procedures such as CABG, which involves the placement of a graft inside the body.
      The global Coronary Artery Bypass Grafts (CABG) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Coronary Artery Bypass Grafts (CABG) market based on company, product type, end user and key regions.

      This report studies the global market size of Coronary Artery Bypass Grafts (CABG) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Coronary Artery Bypass Grafts (CABG) in these regions.
      This research report categorizes the global Coronary Artery Bypass Grafts (CABG) market by top players/brands, region, type and end user. This report also studies the global Coronary Artery Bypass Grafts (CABG) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Medtronic
      Abbott
      MAQUET
      Terumo Medical
      Boston Scientific
      Edwards Lifesciences
      Ethicon (a subsidiary of Johnson & Johnson)
      Karl Storz
      Dextera Surgical
      HeartWare
      Neograft
      Novadaq Technologies Inc
      Teleflex
      Genesee BioMedical

      Market size by Product
      Off-pump CABG
      On-pump CABG
      MI Direct CABG
      Market size by End User
      Hospitals
      Clinics
      Ambulatory Surgical Centers (ASCs)
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Coronary Artery Bypass Grafts (CABG) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Coronary Artery Bypass Grafts (CABG) market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Coronary Artery Bypass Grafts (CABG) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Coronary Artery Bypass Grafts (CABG) submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Coronary Artery Bypass Grafts (CABG) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Coronary Artery Bypass Grafts (CABG) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now